Pfizer/BioNTech Covid vaccine confirmed to protect 95% in largest study yet
Pfizer/BioNTech Covid vaccine confirmed to protect 95% in largest study yet
The largest real-world study yet of the Pfizer/BioNTech vaccine has confirmed that the jab provided more than 95 percent protection against Covid-19.
advertisement
UPDATED: May 6, 2021 14:35 IST
Before Thursday, the largest real-world study of the Pfizer/BioNTec vaccine, also in Israel, was nearly five times smaller, involving 1.2 million people. (AFP)
The largest real-world study yet of the Pfizer/BioNTech vaccine on Thursday confirmed that the jab provided more than 95 percent protection against Covid-19, but found that the level dropped significantly when people received just one of the two prescribed doses.
World s First Fibre-Optic Ultrasonic Imaging Probe For Future Nanoscale Disease Diagnostics
Scientists at the University of Nottingham have developed an ultrasonic imaging system, which can be deployed on the tip of a hair-thin optical fibre, and will be insertable into the human body to visualise cell abnormalities in 3D.
The new technology produces microscopic and nanoscopic resolution images that will one day help clinicians to examine cells inhabiting hard-to-reach parts of the body, such as the gastrointestinal tract, and offer more effective diagnoses for diseases ranging from gastric cancer to bacterial meningitis.
The high level of performance the technology delivers is currently only possible in state-of-the-art research labs with large, scientific instruments - whereas this compact system has the potential to bring it into clinical settings to improve patient care.
Pfizer/BioNTech jab confirmed to protect 95% in largest study yet | Bangladesh Sangbad Sangstha (BSS) bssnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bssnews.net Daily Mail and Mail on Sunday newspapers.
Date Time
Partnership launched to fast track drug discovery
The University of Nottingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.
The University of Nottingham is one of four universities selected by drug development company Evotec SE and global pharmaceutical company Bristol Myers Squibb to be part of the newly formed beLAB1407.
Evotec, together with Bristol-Myers Squibb Company (NYSE: BMY), has launched beLAB1407, a new $20 m academic BRIDGE to identify and advance novel and breakthrough drug discovery opportunities across therapeutic areas from the UK’s top-tier academic institutions. Through a unique combination of Evotec’s drug discovery and development platforms and early-stage therapeutic concepts from the Universities of Nottingham, Birmingham, Edinburgh and Dundee, beLAB1407 offers a unique route to the advancement of first-in-class therapeutics and the creation of spin-ou
Pfizer/BioNTec vaccines proved 95% effective, finds the largest study
Health
Thu, May 06, 2021
PARIS: The largest real-world study yet of the Pfizer/BioNTec vaccine on Thursday confirmed that the jab provided more than 95 percent protection against Covid-19, but found that the level dropped significantly when people received just one of the two prescribed doses.
The authors of the research from Israel´s national vaccination campaign said it showed real-world proof that the pandemic could be ended by rapid, global vaccination programmes.
An analysis of public health data from Israel one of the countries with the highest proportion of fully vaccinated adults showed the vaccine was extremely effective in protecting even elderly individuals at a time when the more infectious English variant was dominant, according to the results published in the Lancet medical journal.